68 Participants Needed

Exercise Training for Breast Cancer

DC
EH
Overseen ByEileen Handberg
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Currently, there are 3.5 million breast cancer survivors in the United States and this number is expected to increase dramatically. The proposed research will examine whether a novel exercise intervention for breast cancer patients who are undergoing chemotherapy protects against cardiovascular dysfunction. Findings may have implications for cardiovascular disease prevention in this population.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you are receiving targeted therapies like CDK4/6 or PARP inhibitors, you cannot participate in this trial.

What data supports the effectiveness of the treatment Exercise training for Breast Cancer?

Research shows that exercise training can help breast cancer patients by reducing side effects of treatment and improving quality of life. Studies have found that both endurance and resistance training during chemotherapy can lead to better outcomes compared to standard care.12345

Is exercise training safe for breast cancer patients?

Exercise training, including aerobic and resistance exercises, is generally safe for breast cancer patients and can help manage side effects like fatigue and loss of muscle strength. However, it is important to have guidance from healthcare professionals to ensure exercises are done safely, especially for those with conditions like lymphedema.26789

How is exercise training different from other treatments for breast cancer?

Exercise training is unique because it not only helps reduce the risk of breast cancer but also significantly improves the quality of life for survivors by reducing fatigue and enhancing physical and immune function. Unlike other treatments, it combines strength and aerobic exercises to maximize benefits and is part of a comprehensive rehabilitation program that can be tailored to individual needs.29101112

Research Team

DC

Demetra Christou, PhD

Principal Investigator

University of Florida

Eligibility Criteria

This trial is for women aged 18-85 with primary invasive non-metastatic breast cancer (stages I-III) who are about to start chemotherapy. Participants must be able to exercise, give consent, and not have severe lymphedema or cardiovascular diseases. It's not for those already doing a lot of aerobic exercise or involved in other experimental studies.

Inclusion Criteria

You don't have any reasons that make exercise unsafe for you.
I have been diagnosed with early-stage (I-III) breast cancer that has not spread.
I am about to start specific chemotherapy before or after surgery.
See 4 more

Exclusion Criteria

You are currently doing a lot of moderate-intensity aerobic exercise each week.
I have a history of significant heart problems.
I am currently on medication specifically for cancer (like CDK4/6 or PARP inhibitors).
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Chemotherapy and Exercise Intervention

Participants undergo chemotherapy while participating in an exercise intervention to evaluate cardiovascular function

12 weeks
Regular visits for exercise sessions and monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Exercise training
Trial Overview The study tests whether a special exercise program can protect the heart and blood vessels from damage during chemotherapy for breast cancer patients. The goal is to see if this can prevent future heart disease in these individuals.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: All-extremity exerciseExperimental Treatment1 Intervention
Group II: Treadmill exerciseActive Control1 Intervention
Group III: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

The Strength after Breast Cancer (SABC) program was successfully implemented in outpatient rehabilitation clinics, with 76% of surveyed clinicians adopting it and 93% continuing to deliver the program, indicating strong sustainability.
The program reached an average of 13 patients per clinic, primarily through referrals from oncology clinics, although barriers such as lack of referrals and competing clinic demands were noted, highlighting areas for improvement in implementation.
Implementing Strength after Breast Cancer (SABC) in outpatient rehabilitation clinics: mapping clinician survey data onto key implementation outcomes.Calo, WA., Doerksen, SE., Spanos, K., et al.[2022]
In a study of 242 breast cancer patients undergoing chemotherapy, those who preferred resistance exercise training (RET) showed significant improvements in quality of life (QoL) when assigned to RET compared to usual care or aerobic exercise training, highlighting the importance of patient preference in exercise interventions.
Demographic and clinical factors, such as marital status, age, chemotherapy regimen, and disease stage, influenced the effectiveness of exercise training, with unmarried, younger patients on nontaxane therapies experiencing better outcomes in terms of strength, lean body mass, and fat loss.
Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial.Courneya, KS., McKenzie, DC., Mackey, JR., et al.[2008]
In a study of 67 breast cancer patients undergoing chemotherapy, both endurance training (ET) and resistance training (RT) significantly improved muscular strength compared to standard care, highlighting the efficacy of exercise during treatment.
Quality of life (QoL) improved significantly in the RT group, while the standard care group experienced a decrease in QoL, suggesting that incorporating exercise into treatment plans can enhance overall well-being for patients.
Comparing Endurance and Resistance Training with Standard Care during Chemotherapy for Patients with Primary Breast Cancer.Schmidt, T., Weisser, B., Dürkop, J., et al.[2019]

References

Implementing Strength after Breast Cancer (SABC) in outpatient rehabilitation clinics: mapping clinician survey data onto key implementation outcomes. [2022]
Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial. [2008]
Comparing Endurance and Resistance Training with Standard Care during Chemotherapy for Patients with Primary Breast Cancer. [2019]
Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. [2022]
[Physical activity and exercise therapy in oncology]. [2023]
Exercise for secondary prevention of breast cancer: moving from evidence to changing clinical practice. [2022]
Resistance Exercise for Breast Cancer Patients? Evidence from the Last Decade. [2022]
Safety of weightlifting among women with or at risk for breast cancer-related lymphedema: musculoskeletal injuries and health care use in a weightlifting rehabilitation trial. [2021]
Multidisciplinary rehabilitation program after breast cancer: benefits on physical function, anthropometry and quality of life. [2018]
Exercise in the prevention and rehabilitation of breast cancer. [2021]
11.Czech Republicpubmed.ncbi.nlm.nih.gov
Breast cancer rehabilitation. [2022]
The role of physical therapy in the rehabilitation of patients with mastectomy and breast reconstruction. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security